biotech / news / / MarketScreener
U.S. President Donald Trump secured agreements with 16 major pharmaceutical companies.
Sixteen major pharmaceutical companies agreed to 'most-favoured-nation' drug pricing for U.S. consumers.
KEY POINTS
- TrumpRx.gov will enable direct-to-consumer drug sales with discounts up to 85% from companies such as Pfizer.
- Novo Nordisk will reduce Ozempic and Wegovy monthly prices from over $1,000 to $350 through TrumpRx.
- Bristol Myers Squibb will provide Eliquis free to Medicaid and donate its active ingredient as part of the deal.
- Regeneron is the only company among 17 major firms not yet to sign such an agreement.
COMPANIES
Summarized by Newsio from MarketScreener. How we summarize →